205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.63%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.29%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.86%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.38%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-0.12%
Negative net income growth while LSCC stands at 63.93%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.26%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
13.02%
Dividend growth of 13.02% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-8.03%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-10.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
70.78%
Similar 10Y revenue/share CAGR to LSCC's 65.29%. Walter Schloss might see both firms benefiting from the same long-term demand.
29.09%
5Y revenue/share CAGR at 50-75% of LSCC's 48.25%. Martin Whitman would worry about a lagging mid-term growth trajectory.
3.75%
3Y revenue/share CAGR under 50% of LSCC's 18.73%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
60.55%
10Y OCF/share CAGR at 50-75% of LSCC's 103.87%. Martin Whitman might fear a structural deficiency in operational efficiency.
50.79%
Positive OCF/share growth while LSCC is negative. John Neff might see a comparative advantage in operational cash viability.
42.19%
Positive 3Y OCF/share CAGR while LSCC is negative. John Neff might see a big short-term edge in operational efficiency.
177.33%
Net income/share CAGR at 75-90% of LSCC's 212.63%. Bill Ackman would press for strategic moves to boost long-term earnings.
49.47%
Below 50% of LSCC's 167.72%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
200.49%
Positive short-term CAGR while LSCC is negative. John Neff would see a clear advantage in near-term profit trajectory.
31.01%
Positive growth while LSCC is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
26.82%
Below 50% of LSCC's 70.02%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.97%
Below 50% of LSCC's 11.66%. Michael Burry suspects a serious short-term disadvantage in building book value.
1232.73%
Dividend/share CAGR of 1232.73% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
183.53%
Dividend/share CAGR of 183.53% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
100.21%
3Y dividend/share CAGR of 100.21% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-15.64%
Firm’s AR is declining while LSCC shows 25.34%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.88%
We show growth while LSCC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.99%
Negative asset growth while LSCC invests at 1.67%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.49%
Under 50% of LSCC's 2.12%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.06%
We’re deleveraging while LSCC stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.33%
Our R&D shrinks while LSCC invests at 1.96%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.34%
We cut SG&A while LSCC invests at 3.72%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.